While neutralizing antibodies that bind to the region preceding immediately to the transmembrane region are reported for HIV envelope glycoprotein, a similar mechanism may be expected to block the infection of SARS-CoV-2 via S protein as it is also a class I fusion protein with a similar structural arrangement (42). Here, ERVW-1 is linked to infection.